Well, they have.... They're picking and choosing. I would say they're cherry-picking. I don't believe the United States is ready to change its intellectual property laws significantly as a result of the TPP. I don't think that will happen. But issues like the biologics industry and the pharmaceutical industry are very powerful and have a lot of influence with the U.S. trade representatives, so they're taking their position—
On March 27th, 2014. See this statement in context.